Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy
International Journal of Molecular Sciences · 17.01.2023 · 24 (3) · 1819
DOI: 10.3390/ijms24031819 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.01.2023. Verfasst von Ling Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, China. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Autistic Disorder. Die Arbeit wurde bisher 224-mal zitiert (Crossref) und nennt 308 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: STI2030-Major Projects, The Research Foundation for Talented Scholars, Nanjing medical University.
Abstract (Originalsprache)
Autism spectrum disorder (ASD) is a heterogeneous, behaviorally defined neurodevelopmental disorder. Over the past two decades, the prevalence of autism spectrum disorders has progressively increased, however, no clear diagnostic markers and specifically targeted medications for autism have emerged. As a result, neurobehavioral abnormalities, neurobiological alterations in ASD, and the development of novel ASD pharmacological therapy necessitate multidisciplinary collaboration. In this review, we discuss the development of multiple animal models of ASD to contribute to the disease mechanisms of ASD, as well as new studies from multiple disciplines to assess the behavioral pathology of ASD. In addition, we summarize and highlight the mechanistic advances regarding gene transcription, RNA and non-coding RNA translation, abnormal synaptic signaling pathways, epigenetic post-translational modifications, brain-gut axis, immune inflammation and neural loop abnormalities in autism to provide a theoretical basis for the next step of precision therapy. Furthermore, we review existing autism therapy tactics and limits and present challenges and opportunities for translating multidisciplinary knowledge of ASD into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
ORCID-Profile: Mingkuan Sun
Förderung
- STI2030-Major Projects
- The Research Foundation for Talented Scholars, Nanjing medical University
Zitieren
APA
Wang, L., Wang, B., Wu, C., Wang, J., & Sun, M. (2023). Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy. International Journal of Molecular Sciences, 24(3), 1819. https://doi.org/10.3390/ijms24031819
Vancouver
Wang L, Wang B, Wu C, Wang J, Sun M. Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy. International Journal of Molecular Sciences. 2023;24(3):1819. doi:10.3390/ijms24031819
BibTeX
@article{Wang2023,
author = {Wang, Ling and Wang, Binquan and Wu, Chunyan and Wang, Jie and Sun, Mingkuan},
title = {Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {1819},
doi = {10.3390/ijms24031819}
}
EUVIMED